TITLE

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-?B2 to p52 via an IKK?/NEMO-independent signalling pathway

AUTHOR(S)
Eliopoulos, Aristides G; Caamano, Jorge H; Flavell, Joanne; Reynolds, Gary M; Murray, Paul G; Poyet, Jean-Luc; Young, Lawrence S
PUB. DATE
October 2003
SOURCE
Oncogene;10/23/2003, Vol. 22 Issue 48, p7557
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The oncogenic Epstein-Barr virus (EBV)-encoded latent infection membrane protein 1 (LMP1) constitutively activates the ‘canonical’ NF-?B pathway that involves the phosphorylation and degradation of I?Ba downstream of the I?B kinases (IKKs). In this study, we show that LMP1 also promotes the proteasome-mediated proteolysis of p100 NF-?B2 resulting in the generation of active p52, which translocates to the nucleus in complex with the p65 and RelB NF-?B subunits. LMP1-induced NF-?B transactivation is reduced in nf-kb2-/- mouse embryo fibroblasts, suggesting that p100 processing contributes to LMP1-mediated NF-?B transcriptional effects. This pathway is likely to operate in vivo, as the expression of LMP1 in primary EBV-positive Hodgkin's lymphoma and nasopharyngeal carcinoma biopsies correlates with the nuclear accumulation of p52. Interestingly, while the ability of LMP1 to activate the canonical NF-?B pathway is impaired in cells lacking IKK?/NEMO, the regulatory subunit of the IKK complex, p100 processing remains unaffected. As a result, nuclear translocation of p52, but not p65, occurs in the absence of IKK?. These data point to the existence of a novel signalling pathway that regulates NF-?B in LMP1-expressing cells, and may thereby play a role in both oncogenic transformation and the establishment of persistent EBV infection.Oncogene (2003) 22, 7557-7569. doi:10.1038/sj.onc.1207120
ACCESSION #
11157978

 

Related Articles

  • NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1. Ersing, Ina; Bernhardt, Katharina; Gewurz, Benjamin E. // Viruses (1999-4915);Jun2013, Vol. 5 Issue 6, p1587 

    The principal Epstein-Barr virus (EBV) oncoprotein, Latent Membrane Protein 1 (LMP1), is expressed in most EBV-associated human malignancies. LMP1 mimics CD40 receptor signaling to provide infected cells with constitutive NF-κB, MAP kinase, IRF7, and PI3 kinase pathway stimulation....

  • Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Kb Activation. Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Battegay, Manuel; El Amari, Emmanuelle Boffi; Dang, Thanh; Egger, Jean-Fran�ois; Fehr, Jan; Mueller-Garamv�gyi, Esther; Parini, Andrea; Schaefer, Stephan C.; Schoeni-Affolter, Franziska; Thurnheer, Christine; Tinguely, Marianne; Telenti, Amalio; Rothenberger, Sylvia // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Epstein-Barr virus (EBV) is associated with several types of cancers including Hodgkin's lymphoma (HL) and nasopharyngeal carcinoma (NPC). EBV-encoded latent membrane protein 1 (LMP1), a multifunctional oncoprotein, is a powerful activator of the transcription factor NF-?B, a property that is...

  • Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Kb Activation. Zuercher, Emilie; Butticaz, Christophe; Wyniger, Josiane; Martinez, Raquel; Battegay, Manuel; El Amari, Emmanuelle Boffi; Dang, Thanh; Egger, Jean-François; Fehr, Jan; Mueller-Garamvögyi, Esther; Parini, Andrea; Schaefer, Stephan C.; Schoeni-Affolter, Franziska; Thurnheer, Christine; Tinguely, Marianne; Telenti, Amalio; Rothenberger, Sylvia // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Epstein-Barr virus (EBV) is associated with several types of cancers including Hodgkin's lymphoma (HL) and nasopharyngeal carcinoma (NPC). EBV-encoded latent membrane protein 1 (LMP1), a multifunctional oncoprotein, is a powerful activator of the transcription factor NF-κB, a property that is...

  • The Role of Epstein-Barr Virus in Neoplastic Transformation. Knecht, Hans; Berger, Christoph; Rothenberger, Sylvia; Odermatt, Bernhard F.; Brousset, Pierre // Oncology;2001, Vol. 60 Issue 4, p289 

    In this review, we focus on new data from basic, translational and clinical research relating to the Epstein-Barr virus (EBV). Beside its well-known tropism for B lymphocytes and epithelial cells, EBV also infects T lymphocytes, monocytes and granulocytes. After primary infection, EBV persists...

  • Epstein--Barr virus latent membrane protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.  // Virology Journal;2011, Vol. 8 Issue 1, p461 

    The article offers information on the study conducted by the authors related to Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies. It states that EBV encoded LMP1 has been shown to increase...

  • Physical Association between the EBV Protein EBNA-1 and P32/TAP/Hyaluronectin. Chen, Mei-Ru; Yang, Jehng-Fen; Wu, Chia-Wei; Middeldorp, Jaap M.; Chen, Jen-Yang // Journal of Biomedical Science;1998, Vol. 5 Issue 3, p173 

    Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA-1) is a protein expressed constitutively during EBV latency. It is required to support the replication of the EBV genome once per cell cycle via the latent origin of replication, oriP. EBNA-1 also can activate transcription through binding to the...

  • The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates. Kyosuke Kanai; Yukio Satoh; Hiroyuki Yamanaka; Kazutaka Horie; Kenji Sugata; Yoshiko Hoshikawa; Tetsutaro Sata; Takeshi Sairenji // Virus Genes;Dec2007, Vol. 35 Issue 3, p563 

    Abstract  A gene of the Epstein-Barr virus (EBV), BamHI-C fragment rightward reading frame 1 (BCRF1), codes viral interleukin-10 (vIL-10), which is a close homolog to human IL-10. EBV strain variations are known at EBV latent membrane protein 1 (LMP1), and the distinct forms of...

  • Epstein-Barr Virus Vaccine for the Prevention of Infectious Mononucleosis-and What Else? Balfour, Jr., Henry H. // Journal of Infectious Diseases;12/15/2007, Vol. 196 Issue 12, p1724 

    The author reflect son the development of the Epstein-Barr Virus (EBV) for the prevention of infectious mononucleosis. EBV is implicated in the pathogenesis of a farrago of diseases, from mild self-limited infections to fulminant malignancies. A vaccine to prevent EBV was proposed in 1973;...

  • Interaction of ubiquitin ligase CBL with LMP2A protein of Epstein-Barr virus occurs via PTB domain of CBL and does not depend on adaptor ITSN1. Dergai, O. V.; Dergai, M. V.; Gudkova, D. O.; Tsyba, L. O.; Skrypkina, I. Ya.; Rynditch, A. V. // Biopolymers & Cell;2013, Vol. 29 Issue 2, p131 

    Previously Latent membrane protein 2A (LMP2A) of Epstein-Barr virus was found to be ubiquitylated by CBL ubiquitin ligase but no direct interaction of LMP2A with CBL was reported. We aimed to explore this interaction and study a possibility of adaptor protein involvement. Taking into...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics